PROJECT PASCAL FORUM

 

Harnessing Emerging Technologies for sustainable future

Dr.Basil Lui Founding Partner August Global Partners

Host: Taeyoung Kang

Organized by Project Pascal

 

Welcome to the Pascal Forum featuring Dr. Basil Lui, a visionary leader at the forefront of innovation and sustainability. With a distinguished career spanning investment, technology, and healthcare, Dr. Lui has played a pivotal role in shaping Singapore’s landscape as a hub for cutting-edge research and development.

As the founding partner of August Global Partners and former managing partner at EDBI, Dr. Lui brings a wealth of expertise in strategic investment and ecosystem building. His strategic foresight has been instrumental in driving investments in emerging technologies, healthcare innovation, and environmental sustainability. By identifying and nurturing promising ventures, Dr. Lui has been instrumental in propelling Singapore to the forefront of global innovation.

Dr. Lui’s unwavering commitment to addressing pressing global challenges, such as climate change and healthcare resilience, underscores his dedication to fostering collaboration between governments, corporations, and research institutions. Through his pioneering initiatives and forward-thinking approach, Dr. Lui continues to inspire positive change and pave the way for a more sustainable and resilient future.

Join us at the Pascal Forum as we engage in insightful discussions with Dr. Basil Lui. Together, we’ll explore the intersection of innovation, sustainability, and economic growth. Drawing inspiration from Dr. Lui’s insights and experiences, we’ll chart a course towards a future defined by innovation, sustainability, and shared prosperity.

 

About Dr. Basil Lui

Dr. Basil Lui is the Founding Partner of AGP. Prior to this, he was an Advisor and Managing Partner at EDBI where he oversaw investments in Healthcare and Emerging Technologies. Dr. Lui was a key member of EDBI’s Investment Committee for ~50 investments with 10 exits. On the healthcare front, he was involved in several investments for EDBI, including Doctor Anywhere a full-stack online-offline healthcare service; Hummingbird Bioscience a clinical-stage precision medicine company; MiRXES a developer of RNA early disease detection tests; US2.ai an AI software platform for echocardiography to fight heart disease; and a pre-covid investment into mRNA vaccine platform Moderna (NASDAQ:MRNA). Basil has a strong interest in regenerative technologies that can restore cellular health and resilience.

Additionally, Dr. Lui drove early stage deep-tech fund-of-funds investments at EDBI, covering regional healthcare funds, and as a LPAC member in portfolio funds, worked closely in partnership with funds to invest in Singapore and the region. He also spearheaded EDBI’s investments in areas that would have an impact to the future of healthcare and the bioeconomy such as synthetic biology, gene edits, robotics, AI, blockchain, AR and VR. Dr. Lui pioneered EDBI’s post-investment value creation and communications efforts, ensuring strong support to portfolio companies through market access, talent recruitment, strategic financing, partnership & guidance; and is often a speaker in global technology events and panels.

Prior to EDBI, Dr. Lui was a McKinsey consultant covering South East Asia, an Adjunct Associate Professor at the Keppel-NUS Corporate Laboratory, the APAC President of a global semiconductor electronic design automation company, an Assistant Professor at National University of Singapore Electrical & Computer Engineering, and a post-doctoral researcher at the Cambridge University Engineering Department. Basil is the inventor of several patents and holds a BA (1st class), MA and PhD from the University of Cambridge. He was awarded a Commonwealth scholarship, a Singapore Government Public Service Commission scholarship, and a Research Fellowship from Trinity College Cambridge.

 

About EDBI 

Investing since 1991, EDBI is a Singapore-based global investor in select high-growth technologies spanning sectors across Information & Communication Technology, Emerging Technology and Healthcare. As a value-creating investor, we support companies aiming to expand in Asia and globally through Singapore with our extensive network, resources and expertise. For more information, visit www.edbi.com.

 

About August Global Partners

August Global Partners (AGP) is an independent fund management company spun out from EDBI, a Singapore state-owned strategic fund, with former top and senior executives as the fund’s founders. Armed with a robust track record and years of success, and having managed significant assets-under-management (AUM) previously, this team will now manage two funds, the AGP Continuation Growth Fund (AGPCG) and a second fund, the AGP Healthcare Fund (AGPHC), to capture new and exciting opportunities. AGPHC is a pure commercially driven fund with Living Better and Aging Better themes.

For more information, visit www.augustglobalpartners.com